Keen Eye Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
21
- Latest Deal Type
-
M&A
Keen Eye General Information
Description
Developer of AI-powered image analysis platform designed to guide better drug development and diagnostics. The company's technology permits doctors and biologists to reproduce and extend their visual expertise, notably by identifying signals with a high predictive value that are difficult to detect, and analyzing tissue samples across any therapeutic area, enabling medical practitioners to save valuable time in day-to-day decision-making.
Contact Information
Website
www.keeneye.aiCorporate Office
- 74 Rue Du Faubourg Saint-Antoine
- 75012 Paris
- France
Corporate Office
- 74 Rue Du Faubourg Saint-Antoine
- 75012 Paris
- France
Keen Eye Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 01-Jan-2023 | Completed | Generating Revenue | |||
| 8. Later Stage VC | 31-Dec-2019 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series A) | 29-Apr-2019 | Completed | Generating Revenue | |||
| 6. Seed Round | 12-Dec-2016 | Completed | Generating Revenue | |||
| 5. Angel (individual) | 15-Jun-2016 | Completed | Startup | |||
| 4. Angel (individual) | 01-Dec-2015 | Completed | Startup | |||
| 3. Angel (individual) | 23-May-2015 | Completed | Startup | |||
| 2. Angel (individual) | 26-Dec-2014 | $142K | $142K | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Keen Eye Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| P-2020 Shares | ||||||||
| P-2019 Shares | ||||||||
| P-2016 Shares | ||||||||
| O Shares | ||||||||
| O Shares | ||||||||
| O Shares | 900 | $0.011107 | $34.12 | $34.12 | 1x | $34.12 | 0.26% | |
| O Shares | 3,800 | $0.011107 | $33.6 | $33.6 | 1x | $33.6 | 1.11% |
Keen Eye Patents
Keen Eye Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021094507-A1 | Method for analysis of a cytology image | Inactive | 13-Nov-2019 | ||
| EP-3593320-A1 | Automated reconstruction method of filament network | Inactive | 07-Mar-2017 | ||
| WO-2018162572-A1 | Automated reconstruction method of filament network | Inactive | 07-Mar-2017 | ||
| WO-2018162941-A1 | Automated reconstruction method of filament network | Inactive | 07-Mar-2017 | ||
| EP-3479339-A1 | Multimodal viewer | Active | 30-Jun-2016 | G06T1/60 |
Keen Eye Signals
Keen Eye Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Crédit Mutuel Equity | Growth/Expansion | Minority | ||
| Seventure | Venture Capital | Minority |
Keen Eye FAQs
-
When was Keen Eye founded?
Keen Eye was founded in 2013.
-
Where is Keen Eye headquartered?
Keen Eye is headquartered in Paris, France.
-
What is the size of Keen Eye?
Keen Eye has 21 total employees.
-
What industry is Keen Eye in?
Keen Eye’s primary industry is Discovery Tools (Healthcare).
-
Is Keen Eye a private or public company?
Keen Eye is a Private company.
-
What is Keen Eye’s current revenue?
The current revenue for Keen Eye is .
-
How much funding has Keen Eye raised over time?
Keen Eye has raised $12M.
-
Who are Keen Eye’s investors?
Crédit Mutuel Equity and Seventure have invested in Keen Eye.
-
When was Keen Eye acquired?
Keen Eye was acquired on 01-Jan-2023.
-
Who acquired Keen Eye?
Keen Eye was acquired by Tribun Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process